VAMP7

Across TCGA pan-cancer cohorts, VAMP7 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated VAMP7 data layer compared with 24 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher VAMP7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated VAMP7 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC, DLBC, and PRAD are the cancer types where VAMP7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.029	0.751	<.001	48	view →
DLBC	OS	Median	All	0.054	0.842	<.001	12	view →
PRAD	DFS	Median	All	0.111	0.886	<.001	8	view →
SKCM	DFS	Median	All	0.489	0.740	.023	4	view →
UCEC	DFS	Median	II,III,IV	0.906	0.439	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

VAMP7–HNSC (OS)

Open the HNSC breakdown →